Overview

Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder

Status:
Not yet recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This is an open trial that seeks to determine the safety and tolerability of using inositol for children and adolescents with bipolar disorder and comorbid anxiety disorders with an exploration of efficacy and dose-response.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ronald M. Glick, MD
University of Pittsburgh
Collaborators:
Jarrow Formulas Inc
The Fine Foundation
Treatments:
Inositol